Dr. Leyla Shune, MD
Claim this profileOlathe Health Cancer Center
Studies Lymphoma
Studies B-Cell Lymphoma
7 reported clinical trials
14 drugs studied
Area of expertise
1Lymphoma
MYC positive
BCL2 positive
BCL6 positive
2B-Cell Lymphoma
MYC positive
BCL2 positive
BCL6 positive
Affiliated Hospitals
Clinical Trials Leyla Shune, MD is currently running
CAR T-Cell Therapy + Ibrutinib
for Chronic Lymphocytic Leukemia
This is a phase I/II study to evaluate the feasibility, safety and preliminary antitumor efficacy of rapcabtagene autoleucel (also known as YTB323). Rapcabtagene autoleucel will be investigated in combination with ibrutinib in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and as single agent in diffuse large B-cell lymphoma (3L+ DLBCL), adult acute lymphoblastic leukemia (ALL) and 1st Line High Risk Large B-Cell Lymphoma (1L HR LBCL).
Recruiting1 award Phase 1 & 212 criteria
Quadruple Therapy
for Multiple Myeloma
This is a single-arm, open-label phase II study with a safety lead-in phase.
Recruiting1 award Phase 29 criteria
More about Leyla Shune, MD
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Leyla Shune, MD has experience with
- Nivolumab
- Varlilumab
- Copanlisib Hydrochloride
- YTB323
- Ibrutinib
- PHE885
Breakdown of trials Leyla Shune, MD has run
Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Leyla Shune, MD specialize in?
Leyla Shune, MD focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved MYC positive patients, or patients who are BCL2 positive.
Is Leyla Shune, MD currently recruiting for clinical trials?
Yes, Leyla Shune, MD is currently recruiting for 2 clinical trials in Olathe Kansas. If you're interested in participating, you should apply.
Are there any treatments that Leyla Shune, MD has studied deeply?
Yes, Leyla Shune, MD has studied treatments such as Nivolumab, Varlilumab, Copanlisib Hydrochloride.
What is the best way to schedule an appointment with Leyla Shune, MD?
Apply for one of the trials that Leyla Shune, MD is conducting.
What is the office address of Leyla Shune, MD?
The office of Leyla Shune, MD is located at: Olathe Health Cancer Center, Olathe, Kansas 66061 United States. This is the address for their practice at the Olathe Health Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.